001     148395
005     20240229123032.0
024 7 _ |a 10.1016/j.cmet.2019.11.010
|2 doi
024 7 _ |a 1550-4131
|2 ISSN
024 7 _ |a 1932-7420
|2 ISSN
024 7 _ |a altmetric:72221916
|2 altmetric
024 7 _ |a pmid:31813823
|2 pmid
037 _ _ |a DKFZ-2019-02950
082 _ _ |a 570
100 1 _ |a Snaebjornsson, Marteinn Thor
|0 P:(DE-He78)7b7131e0870c28d432e48873d295460f
|b 0
|e First author
245 _ _ |a Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer
260 _ _ |a Cambridge, Mass.
|c 2020
|b Cell Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1603107283_18443
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a PMID: 31813823Grants:FOR2314, SCHU2670/1bei Fragen bitte Anna Lück kontaktieren#EA:A410#LA:A410#2020 Jan 7;31(1):62-76
520 _ _ |a Altered lipid metabolism is among the most prominent metabolic alterations in cancer. Enhanced synthesis or uptake of lipids contributes to rapid cancer cell growth and tumor formation. Lipids are a highly complex group of biomolecules that not only constitute the structural basis of biological membranes but also function as signaling molecules and an energy source. Here, we summarize recent evidence implicating altered lipid metabolism in different aspects of the cancer phenotype and discuss potential strategies by which targeting lipid metabolism could provide a therapeutic window for cancer treatment.
536 _ _ |a 311 - Signalling pathways, cell and tumor biology (POF3-311)
|0 G:(DE-HGF)POF3-311
|c POF3-311
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Janaki-Raman, Sudha
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Schulze, Almut
|0 P:(DE-He78)94ae391f53fb9285e1b68f9930615af1
|b 2
|e Last author
773 _ _ |a 10.1016/j.cmet.2019.11.010
|g p. S1550413119306175
|0 PERI:(DE-600)2174469-5
|n 1
|p 62-76
|t Cell metabolism
|v 31
|y 2020
|x 1550-4131
909 C O |p VDB
|o oai:inrepo02.dkfz.de:148395
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)7b7131e0870c28d432e48873d295460f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)94ae391f53fb9285e1b68f9930615af1
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-311
|2 G:(DE-HGF)POF3-300
|v Signalling pathways, cell and tumor biology
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2020
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CELL METAB : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 20
|0 StatID:(DE-HGF)9920
|2 StatID
|b CELL METAB : 2017
920 2 _ |0 I:(DE-He78)A410-20160331
|k A410
|l Tumor Metabolismus und Microenvironment
|x 0
920 0 _ |0 I:(DE-He78)A410-20160331
|k A410
|l Tumor Metabolismus und Microenvironment
|x 0
920 1 _ |0 I:(DE-He78)A410-20160331
|k A410
|l Tumor Metabolismus und Microenvironment
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)A410-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21